 LiveScience.com |
Asthma Worse In Children, Novartis' Xolair Recommended
Medical News Today A new study suggests that Novartis drug Xolair may aid in the treatment of asthma, the leading cause of chronic illness in children, especially for those living in highly polluted inner-city areas. Asthma affects as many as 10% to 12% of children in … Omalizumab 'cuts seasonal asthma attacks in youth' Omalizumab improves asthma control in inner-city children Drug may relieve kids' asthma in the fall |
View full post on asthma – Google News